- Home
- TSHA vs KTF Comparison
TSHA vs KTF Comparison
Compare TSHA & KTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- KTF
- Stock Information
- Founded
- TSHA 2019
- KTF 1988
- Country
- TSHA United States
- KTF United States
- Employees
- TSHA N/A
- KTF N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- KTF Finance Companies
- Sector
- TSHA Health Care
- KTF Finance
- Exchange
- TSHA Nasdaq
- KTF Nasdaq
- Market Cap
- TSHA 334.1M
- KTF 369.8M
- IPO Year
- TSHA 2020
- KTF N/A
- Fundamental
- Price
- TSHA $1.72
- KTF $9.35
- Analyst Decision
- TSHA Strong Buy
- KTF
- Analyst Count
- TSHA 8
- KTF 0
- Target Price
- TSHA $6.63
- KTF N/A
- AVG Volume (30 Days)
- TSHA 1.5M
- KTF 103.3K
- Earning Date
- TSHA 02-26-2025
- KTF 01-01-0001
- Dividend Yield
- TSHA N/A
- KTF 3.54%
- EPS Growth
- TSHA N/A
- KTF N/A
- EPS
- TSHA N/A
- KTF 0.39
- Revenue
- TSHA $8,333,000.00
- KTF N/A
- Revenue This Year
- TSHA N/A
- KTF N/A
- Revenue Next Year
- TSHA N/A
- KTF N/A
- P/E Ratio
- TSHA N/A
- KTF $23.10
- Revenue Growth
- TSHA N/A
- KTF N/A
- 52 Week Low
- TSHA $1.19
- KTF $7.40
- 52 Week High
- TSHA $4.32
- KTF $9.12
- Technical
- Relative Strength Index (RSI)
- TSHA 54.31
- KTF 29.12
- Support Level
- TSHA $1.66
- KTF $9.45
- Resistance Level
- TSHA $1.77
- KTF $9.77
- Average True Range (ATR)
- TSHA 0.11
- KTF 0.09
- MACD
- TSHA 0.01
- KTF -0.04
- Stochastic Oscillator
- TSHA 47.62
- KTF 2.33
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About KTF DWS Municipal Income Trust
DWS Municipal Income Trust is a closed-end, diversified investment management company. The investment objective is to provide high current income exempt from federal income tax by investing in a diversified portfolio of investment-grade tax-exempt securities. Its products include ETFs, Mutual Funds, Closed-End-Funds, Money Market Funds, and others.